Deutsche Bank’s Stoke Therapeutics STOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $230K | Sell |
20,303
-5,263
| -21% | -$59.7K | ﹤0.01% | 2870 |
|
|
2025
Q1 | $170K | Sell |
25,566
-325,048
| -93% | -$2.16M | ﹤0.01% | 3003 |
|
|
2024
Q4 | $3.87M | Sell |
350,614
-111,861
| -24% | -$1.23M | ﹤0.01% | 1454 |
|
|
2024
Q3 | $5.68M | Buy |
462,475
+446,445
| +2,785% | +$5.49M | ﹤0.01% | 1220 |
|
|
2024
Q2 | $217K | Sell |
16,030
-396,210
| -96% | -$5.35M | ﹤0.01% | 2728 |
|
|
2024
Q1 | $5.57M | Sell |
412,240
-538
| -0.1% | -$7.26K | ﹤0.01% | 1213 |
|
|
2023
Q4 | $2.17M | Buy |
412,778
+399,016
| +2,899% | +$2.1M | ﹤0.01% | 1617 |
|
|
2023
Q3 | $54.2K | Sell |
13,762
-556,749
| -98% | -$2.19M | ﹤0.01% | 3364 |
|
|
2023
Q2 | $6.06M | Sell |
570,511
-146,406
| -20% | -$1.56M | ﹤0.01% | 1173 |
|
|
2023
Q1 | $5.97M | Sell |
716,917
-30,869
| -4% | -$257K | ﹤0.01% | 1164 |
|
|
2022
Q4 | $6.9M | Sell |
747,786
-39,099
| -5% | -$361K | ﹤0.01% | 1105 |
|
|
2022
Q3 | $10.1M | Sell |
786,885
-1,496
| -0.2% | -$19.2K | 0.01% | 951 |
|
|
2022
Q2 | $10.4M | Buy |
788,381
+516,495
| +190% | +$6.82M | 0.01% | 980 |
|
|
2022
Q1 | $5.72M | Buy |
271,886
+247,555
| +1,017% | +$5.21M | ﹤0.01% | 1353 |
|
|
2021
Q4 | $584K | Sell |
24,331
-2,864
| -11% | -$68.7K | ﹤0.01% | 2720 |
|
|
2021
Q3 | $693K | Buy |
27,195
+14,628
| +116% | +$373K | ﹤0.01% | 2833 |
|
|
2021
Q2 | $423K | Buy |
12,567
+3,499
| +39% | +$118K | ﹤0.01% | 3310 |
|
|
2021
Q1 | $352K | Sell |
9,068
-141
| -2% | -$5.47K | ﹤0.01% | 3303 |
|
|
2020
Q4 | $570K | Buy |
9,209
+2,474
| +37% | +$153K | ﹤0.01% | 2805 |
|
|
2020
Q3 | $225K | Buy |
6,735
+590
| +10% | +$19.7K | ﹤0.01% | 3121 |
|
|
2020
Q2 | $146K | Buy |
6,145
+235
| +4% | +$5.58K | ﹤0.01% | 3228 |
|
|
2020
Q1 | $135K | Buy |
5,910
+2,659
| +82% | +$60.7K | ﹤0.01% | 3087 |
|
|
2019
Q4 | $91K | Buy |
3,251
+426
| +15% | +$11.9K | ﹤0.01% | 3556 |
|
|
2019
Q3 | $59K | Buy |
+2,825
| New | +$59K | ﹤0.01% | 3737 |
|